ArticleMolecular medicine (Cambridge, Mass.)2021

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma.

Muhammad Babar Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.